These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33718247)

  • 1. Multi-Institutional Retrospective Study of Radiotherapy for Hepatocellular Carcinoma in the Caudate Lobe.
    Lee SU; Yoon SM; Cheng JC; Kim TH; Kim BH; Park JH; Jung J; Tsai CL; Chiang Y; Park JW
    Front Oncol; 2021; 11():646473. PubMed ID: 33718247
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.
    Kim TH; Lee KS; Sim SH; Kim YJ; Kim DY; Chae H; Lee EG; Han JH; Jung SY; Lee S; Kang HS; Lee ES
    Front Oncol; 2021; 11():783327. PubMed ID: 34804986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.
    English K; Brodin NP; Shankar V; Zhu S; Ohri N; Golowa YS; Cynamon J; Bellemare S; Kaubisch A; Kinkhabwala M; Kalnicki S; Garg MK; Guha C; Kabarriti R
    JAMA Netw Open; 2020 Nov; 3(11):e2023942. PubMed ID: 33151315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy
    Kutuk T; Herrera R; Mustafayev TZ; Gungor G; Ugurluer G; Atalar B; Kotecha R; Hall MD; Rubens M; Mittauer KE; Contreras JA; McCulloch J; Kalman NS; Alvarez D; Romaguera T; Gutierrez AN; Garcia J; Kaiser A; Mehta MP; Ozyar E; Chuong MD
    Adv Radiat Oncol; 2022; 7(6):100978. PubMed ID: 35647412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma.
    Lee DY; Park JW; Kim TH; Lee JH; Kim BH; Woo SM; Kim SS; Lee WJ; Kim DY; Kim CM
    Strahlenther Onkol; 2015 Nov; 191(11):835-44. PubMed ID: 26174506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study.
    Liu B; Long J; Wang W; Huang T; Xie X; Chen S; Huang G; Jiang C; Ye J; Long H; Xie X; Kuang M
    BMC Cancer; 2019 Jul; 19(1):699. PubMed ID: 31311502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion radiotherapy for patients with hepatocellular carcinoma in the caudate lobe carbon ion radiotherapy for hepatocellular carcinoma in caudate lobe.
    Okazaki S; Shibuya K; Shiba S; Okamoto M; Miyasaka Y; Osu N; Kawashima M; Kakizaki S; Araki K; Shirabe K; Ohno T
    Hepatol Res; 2021 Mar; 51(3):303-312. PubMed ID: 33350034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caudate lobe hepatocellular carcinoma treated with selective chemoembolization.
    Kim HC; Chung JW; Jae HJ; Yoon JH; Lee JH; Kim YJ; Lee HS; Yoon CJ; Park JH
    Radiology; 2010 Oct; 257(1):278-87. PubMed ID: 20697120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation for hepatocellular carcinoma located in the caudate lobe of the liver.
    Hatanaka T; Kakizaki S; Yuhei S; Takeuchi S; Shimada Y; Takizawa D; Katakai K; Sato K; Yamada M
    Acta Gastroenterol Belg; 2015; 78(3):267-73. PubMed ID: 26448406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.
    Elganainy D; Holliday EB; Taniguchi CM; Smith GL; Shroff R; Javle M; Raghav K; Kaseb A; Aloia TA; Vauthey JN; Tzeng CD; Herman JM; Koong AC; Krishnan SX; Minsky BD; Crane CH; Das P; Koay EJ
    Cancer Med; 2018 Oct; 7(10):4880-4892. PubMed ID: 30152073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma.
    Pao TH; Hsueh WT; Chang WL; Chiang NJ; Lin YJ; Liu YS; Lin FC
    BMC Cancer; 2019 Jun; 19(1):560. PubMed ID: 31182065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
    Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
    J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose Thoracic Re-irradiation of Lung Cancer Using Highly Conformal Radiotherapy Is Effective with Acceptable Toxicity.
    Hong JH; Kim YS; Lee SW; Lee SJ; Kang JH; Hong SH; Hong JY; Cheon G
    Cancer Res Treat; 2019 Jul; 51(3):1156-1166. PubMed ID: 30514067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Algorithm for Liver Resection of Hepatocellular Carcinoma in the Caudate Lobe.
    Yoshida N; Midorikawa Y; Higaki T; Nakayama H; Moriguchi M; Aramaki O; Tsuji S; Okamura Y; Takayama T
    World J Surg; 2022 May; 46(5):1134-1140. PubMed ID: 35119511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.
    Kim TH; Woo SM; Lee WJ; Chun JW; Cho YR; Kim BH; Koh YH; Kim SS; Oh ES; Lee DY; Lee SU; Suh YG; Moon SH; Park JW
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma.
    Zhang T; Zhao YT; Wang Z; Li CR; Jin J; Jia AY; Wang SL; Song YW; Liu YP; Ren H; Fang H; Bao H; Liu XF; Yu ZH; Li YX; Wang WH
    Medicine (Baltimore); 2016 May; 95(21):e3789. PubMed ID: 27227954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.